- Home
- INTS vs NAAS Comparison
INTS vs NAAS Comparison
Compare INTS & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTS
- NAAS
- Stock Information
- Founded
- INTS 2012
- NAAS 2019
- Country
- INTS United States
- NAAS China
- Employees
- INTS N/A
- NAAS N/A
- Industry
- INTS Biotechnology: Pharmaceutical Preparations
- NAAS Other Specialty Stores
- Sector
- INTS Health Care
- NAAS Consumer Discretionary
- Exchange
- INTS Nasdaq
- NAAS Nasdaq
- Market Cap
- INTS 9.4M
- NAAS 8.3M
- IPO Year
- INTS 2023
- NAAS 2017
- Fundamental
- Price
- INTS $0.32
- NAAS $0.85
- Analyst Decision
- INTS Strong Buy
- NAAS
- Analyst Count
- INTS 3
- NAAS 0
- Target Price
- INTS $8.50
- NAAS N/A
- AVG Volume (30 Days)
- INTS 2.7M
- NAAS 1.6M
- Earning Date
- INTS 08-07-2025
- NAAS 07-23-2025
- Dividend Yield
- INTS N/A
- NAAS N/A
- EPS Growth
- INTS N/A
- NAAS N/A
- EPS
- INTS N/A
- NAAS N/A
- Revenue
- INTS N/A
- NAAS $43,258,393.00
- Revenue This Year
- INTS N/A
- NAAS $19.53
- Revenue Next Year
- INTS N/A
- NAAS $151.36
- P/E Ratio
- INTS N/A
- NAAS N/A
- Revenue Growth
- INTS N/A
- NAAS 50.34
- 52 Week Low
- INTS $0.26
- NAAS $0.60
- 52 Week High
- INTS $5.10
- NAAS $41.80
- Technical
- Relative Strength Index (RSI)
- INTS 37.08
- NAAS 33.62
- Support Level
- INTS $0.28
- NAAS $0.60
- Resistance Level
- INTS $0.32
- NAAS $0.96
- Average True Range (ATR)
- INTS 0.06
- NAAS 0.14
- MACD
- INTS 0.01
- NAAS -0.01
- Stochastic Oscillator
- INTS 7.43
- NAAS 22.99
About INTS Intensity Therapeutics Inc. Common stock
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.